Compound Detail
CHEMBL1230607
PHA-793887 Phase I
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Phase I
Basic Information
| ChEMBL ID | CHEMBL1230607 |
| Name | PHA-793887 |
| Phase | Phase I |
| Structure Type | MOL |
| InChI Key | HUXYBQXJVXOMKX-UHFFFAOYSA-N |
40
Targets
44
Activities
2
Assay Types
4
PK Parameters
20
Publications
1
Known Names
1
Indications
1
Mechanisms
Molecular Properties
361.5
MW (Da)
2.31
ALogP
4
HBA
2
HBD
81.3
PSA (Ų)
0.86
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Cyclin-dependent kinase inhibitor | INHIBITOR | Cyclin-dependent kinase | ✓ | ✓ |
Indications
Neoplasms
Activity Summary
Kd 24 meas. best 8.52
IC50 20 meas. best 8.3
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Phenylalanine--tRNA ligase beta subunit CHEMBL4105969 | Kd | 8.52 | 8.52 | 3.0 | 1 |
| Cyclin-dependent kinase 5/CDK5 activator 1 CHEMBL1907600 | IC50 | 8.3 | 8.3 | 5.0 | 1 |
| Cyclin-dependent kinase 5 CHEMBL4036 | IC50 | 8.3 | 8.3 | 5.0 | 1 |
| Dual specificity protein kinase CLK2 CHEMBL4225 | Kd | 8.15 | 8.15 | 7.0 | 1 |
| Cyclin-dependent kinase 2 CHEMBL301 | IC50 | 8.1 | 8.1 | 8.0 | 1 |
| Cyclin-dependent kinase 3 CHEMBL4442 | Kd | 8.1 | 8.1 | 8.0 | 1 |
| Cyclin-dependent kinase 7 CHEMBL3055 | Kd | 8.1 | 8.1 | 8.0 | 1 |
| Cyclin-dependent kinase 2/cyclin E1 CHEMBL1907605 | IC50 | 8.1 | 8.1 | 8.0 | 1 |
| Cyclin-dependent kinase 2/cyclin A CHEMBL2094128 | IC50 | 8.1 | 8.1 | 8.0 | 1 |
| General transcription and DNA repair factor IIH helicase subunit XPD CHEMBL4105743 | Kd | 8.0 | 8.0 | 10.0 | 1 |
| Cyclin-dependent kinase 7 CHEMBL3055 | IC50 | 8.0 | 8.0 | 10.0 | 1 |
| Cyclin-dependent kinase 7/ cyclin H CHEMBL2111288 | IC50 | 8.0 | 8.0 | 10.0 | 1 |
| Glycogen synthase kinase-3 beta CHEMBL262 | Kd | 7.92 | 7.92 | 12.0 | 1 |
| Glycogen synthase kinase-3 alpha CHEMBL2850 | Kd | 7.54 | 7.54 | 29.0 | 1 |
| Cyclin-dependent kinase 1/cyclin B1 CHEMBL1907602 | IC50 | 7.22 | 7.22 | 60.0 | 1 |
| Cyclin-dependent kinase 4/cyclin D1 CHEMBL1907601 | IC50 | 7.21 | 7.21 | 62.0 | 1 |
| Serine/threonine-protein kinase D3 CHEMBL2595 | Kd | 7.19 | 7.19 | 65.0 | 1 |
| Glycogen synthase kinase-3 beta CHEMBL262 | IC50 | 7.1 | 7.1 | 79.0 | 1 |
| A2780 CHEMBL614004 | IC50 | 7.05 | 7.05 | 90.0 | 1 |
| Cyclin-dependent kinase 2 CHEMBL301 | Kd | 7.01 | 7.01 | 98.0 | 1 |
| Serine/threonine-protein kinase D2 CHEMBL4900 | Kd | 6.99 | 6.99 | 103.0 | 1 |
| Cyclin-dependent kinase 5 CHEMBL4036 | Kd | 6.87 | 6.87 | 135.0 | 1 |
| CDK9/cyclin T1 CHEMBL2111389 | IC50 | 6.86 | 6.86 | 138.0 | 1 |
| HCT-116 CHEMBL394 | IC50 | 6.79 | 6.79 | 163.0 | 1 |
| Serine/threonine-protein kinase 26 CHEMBL5941 | Kd | 6.76 | 6.76 | 175.0 | 1 |
| COLO 205 CHEMBL614561 | IC50 | 6.73 | 6.73 | 188.0 | 1 |
| Cyclin-dependent kinase 9 CHEMBL3116 | Kd | 6.66 | 6.66 | 218.0 | 1 |
| Mitogen-activated protein kinase 15 CHEMBL5198 | Kd | 6.58 | 6.58 | 264.0 | 1 |
| NON-PROTEIN TARGET CHEMBL3879801 | IC50 | 6.54 | 6.54 | 285.0 | 1 |
| DU-145 CHEMBL613508 | IC50 | 6.52 | 6.52 | 303.0 | 1 |
| A-375 CHEMBL613859 | IC50 | 6.4 | 6.4 | 396.0 | 1 |
| Cyclin-dependent kinase 16 CHEMBL4597 | Kd | 6.35 | 6.35 | 444.0 | 1 |
| PC-3 CHEMBL390 | IC50 | 6.22 | 6.22 | 601.0 | 1 |
| Serine/threonine-protein kinase ULK1 CHEMBL6006 | Kd | 6.08 | 6.08 | 838.0 | 1 |
| Serine/threonine-protein kinase PAK 4 CHEMBL4482 | Kd | 6.06 | 6.06 | 864.0 | 1 |
| Phosphorylase b kinase gamma catalytic chain, liver/testis isoform CHEMBL2349 | Kd | 6.0 | 6.0 | 1002.0 | 1 |
| MCF7 CHEMBL387 | IC50 | 5.89 | 5.89 | 1284.0 | 1 |
| Dual specificity protein kinase CLK1 CHEMBL4224 | Kd | 5.66 | 5.66 | 2184.0 | 1 |
| Mitogen-activated protein kinase 3 CHEMBL3385 | Kd | 5.63 | 5.63 | 2330.0 | 1 |
| Protein kinase C theta type CHEMBL3920 | Kd | 5.63 | 5.63 | 2341.0 | 1 |
| Cyclin-dependent kinase 1 CHEMBL308 | Kd | 5.59 | 5.59 | 2565.0 | 1 |
| BXPC-3 CHEMBL614530 | IC50 | 5.46 | 5.46 | 3444.0 | 1 |
| Cyclin-dependent kinase 13 CHEMBL1795192 | Kd | 5.45 | 5.45 | 3582.0 | 1 |
| Cyclin-dependent kinase 12 CHEMBL3559692 | Kd | 5.44 | 5.44 | 3657.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 6940.61 | ng.hr.mL-1 | Mus musculus |
| CL | 23.9 | mL.min-1.kg-1 | Mus musculus |
| Cmax | 36500.0 | nM | Mus musculus |
| T1/2 | 4.1 | hr | Mus musculus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL4689842 | U2OS | 262 |
| - | 10.6019/CHEMBL4689842 | Fibroblast | 262 |
| - | 10.6019/CHEMBL4689842 | HEK-293T | 261 |
| 20153204 | 10.1016/j.bmc.2010.01.042 | A2780 | 13 |
| 20153204 | 10.1016/j.bmc.2010.01.042 | Unchecked | 8 |
| 20153204 | 10.1016/j.bmc.2010.01.042 | Mus musculus | 8 |
| 29191878 | 10.1126/science.aan4368 | Unchecked | 5 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 4 |
| 20153204 | 10.1016/j.bmc.2010.01.042 | Cyclin-dependent kinase | 4 |
| 20153204 | 10.1016/j.bmc.2010.01.042 | HCT-116 | 3 |
| 20153204 | 10.1016/j.bmc.2010.01.042 | No relevant target | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| 20153204 | 10.1016/j.bmc.2010.01.042 | BXPC-3 | 2 |
| - | 10.6019/CHEMBL4495564 | Replicase polyprotein 1ab | 2 |
| 20153204 | 10.1016/j.bmc.2010.01.042 | cAMP-dependent protein kinase catalytic subunit alpha | 1 |
| 38157838 | 10.1016/j.bmc.2023.117561 | Unchecked | 1 |
| 20153204 | 10.1016/j.bmc.2010.01.042 | Serine/threonine-protein kinase PAK 4 | 1 |
| 20153204 | 10.1016/j.bmc.2010.01.042 | [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial | 1 |
| 20153204 | 10.1016/j.bmc.2010.01.042 | Proto-oncogene tyrosine-protein kinase receptor Ret | 1 |
| 20153204 | 10.1016/j.bmc.2010.01.042 | High affinity nerve growth factor receptor | 1 |
Data from ChEMBL 36 via Core Engine